Exchange: OTC·Updated 10:53 AM EST

BIOYF BioSyent Inc.

$12.47
$0.02
(0.16%)
Today
EarningsMar 18
Mkt Cap$141.25M
Vol790.00

About BIOYF

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.
50

Neutral Sentiment

How do you feel about BIOYF?

Advertisement|Remove ads.